Darian Fentos

Independent Researcher

The legal fight of the century. Robert Barnes discusses what people can do when faced with mandatory injections in the workplace.

CLICK HERE to watch full interview.

Is the Janssen Covid jab safe for breastfed infants and pregnant women? Let's ask Health Canada:

“The safety and efficacy of the Janssen COVID-19 Vaccine in pregnant women have not yet been established.” (Sect. 7.1, p. 8)

“It is not known whether the components of Janssen COVID-19 Vaccine or antibodies induced by Janssen COVID-19 Vaccine are excreted in human milk. Human data are not available to assess the impact of Janssen COVID-19 Vaccine on milk production or its effects on the breastfed child.” (Sect. 7.1, p. 8)

I guess the answer is no.

Moderna

Coronavirus disease (COVID-19) > Authorized vaccines > Approved COVID-19 Vaccines > Moderna COVID-19 vaccine > Authorized with conditions > Moderna regulatory information > For health care professionals > Product Monograph

Pfizer-BioNTech

Coronavirus disease (COVID-19) > Authorized vaccines > Approved COVID-19 Vaccines > Pfizer-BioNTech COVID-19 vaccine > Authorization information > Pfizer-BioNTech regulatory information > For health care professionals > Product Monograph

AstraZeneca

Coronavirus disease (COVID-19) > Authorized vaccines > Approved COVID-19 Vaccines > AstraZeneca/COVISHIELD COVID-19 vaccine > Authorization information > AstraZeneca regulatory information > For health care professionals > Product Monograph

Janssen

Coronavirus disease (COVID-19) > Authorized vaccines > Approved COVID-19 Vaccines > Janssen (Johnson & Johnson) COVID-19 vaccine > Authorization information > Janssen regulatory information > For health care professionals > Product Monograph

TGA (Australia)

Start right here: COVID-19 vaccines.

After clicking on the link above, you will be presented with a number of options.

Select Provisional registrations.

From there you will have four companies/sponsors listed: Pfizer, AstraZeneca, Janssen-Cilag, and Moderna.

To access product information for each company, click on the product name you want to view; i.e.:

  • COMIRNATY – BNT162b2 [mRNA]
  • COVID-19 Vaccine AstraZeneca
  • COVID-19 Vaccine Janssen
  • Spikevax (elasomeran)

Once you have chosen and clicked on the product(s), look for the list of documents beneath the heading, Supporting regulatory documents.

Find the PDF titled, Product Information (PI). Click on it.

To simplify the process, I have directly linked to each Product Information sheet below:

  • Pfizer: PDF
  • AstraZeneca: PDF
  • Janssen-Cilag: PDF
  • Moderna: PDF

It is essential to study these documents closely. They demonstrate the lack of adequate long-term safety data underpinning each product, whilst pointing out the various unknown/potential effects. Furthermore, known adverse events (including 'fatal outcomes') are listed.

The mass media will not provide this analysis for you.

FDA (United States)

Start right here: COVID-19 Vaccines – FDA.

After clicking on the link above, you will see a list of products under the heading, COVID-19 Vaccines Authorized for Emergency Use.

Once you have selected the product you want to view (i.e. Pfizer-BioNTech, Moderna, or Janssen), then click on the blue box titled, Fact Sheets and FAQs, which will bring up a list of documents.

Then, download the Fact Sheet for Healthcare Providers Administering Vaccine.

To make it easier, here is a direct link to each document:

It is essential to study these documents, as they provide details about the vaccines that you will not hear reported in the mass media.

In most human beings, there is always a 'line in the sand' they are unwilling to cross. In the Covid era, perhaps this line will prove to be the use of experimental vaccines on children. You may be under the impression, due to 24/7 media saturation, that these new vaccines are all fully approved. This is not the case.

In Australia, the Covid-19 vaccines are referred to, 'provisional' by the TGA; in the USA, they are called 'unapproved products' by the FDA; in Canada, they are come under 'interim authorization'; and in the UK, 'temporary authorisation' is the preferred term. Regulatory agencies assure us that they are closely monitoring the population for safety issues as vaccine uptake increases. In other words, they are keeping a close eye on the ongoing experiment. Consider the following example, from the FDA:

“Additional adverse reactions, some of which may be serious, may become apparent with more widespread use of the Pfizer-BioNTech COVID-19 Vaccine.” (FDA, p. 8)

Let's consider just one of those potential serious adverse events – Multisystem Inflammatory Syndrome in Children (MIS‐C). Scientists have already expressed deep concerns:

“This kind of inflammatory risk makes vaccine development particularly challenging in the pediatric population. If the vaccine is able to induce this type of antibody response, then it would potentially place otherwise healthy children at risk of severe outcome following vaccination intended to prevent illness from SARS‐CoV‐2. Even in small numbers, this is highly concerning. It thus is critical to have a deeper understanding of the pathophysiology and mechanisms associated with those that develop MIS‐C in order to effectively study vaccines in the pediatric population. Only by rigorously studying the vaccine candidates for links to potential MIS‐C causes can we create the safety profile needed for large scale vaccination of the world’s pediatric population.” (Blumenthal & Burns 2020)

“We need to continue to monitor for MIS-C/A after SARS-CoV-2 infection and immunization as more of the population are vaccinated, especially as vaccines are administered to children who are at higher risk for MIS. CDC and the US Food and Drug Administration co-manage VAERS (the Vaccine Adverse Event Reporting System), which is being used to monitor for adverse events after COVID-19 vaccines. MIS-C/A is listed as a postvaccination adverse event of special interest (5) and should be reported to VAERS (6).” (Salzman et al. 2021)

Is this your line in the sand, as a parent? Will you offer your child up as part of the ongoing experiment? With all the recent talk of mandatory vaccination for school children, perhaps this is the time for parents to revisit Article 6 of the Universal Declaration on Bioethics and Human Rights:

“Scientific research should only be carried out with the prior, free, express and informed consent of the person concerned. The information should be adequate, provided in a comprehensible form and should include modalities for withdrawal of consent. Consent may be withdrawn by the person concerned at any time and for any reason without any disadvantage or prejudice. Exceptions to this principle should be made only in accordance with ethical and legal standards adopted by States, consistent with the principles and provisions set out in this Declaration, in particular in Article 27, and international human rights law.”

“In appropriate cases of research carried out on a group of persons or a community, additional agreement of the legal representatives of the group or community concerned may be sought. In no case should a collective community agreement or the consent of a community leader or other authority substitute for an individual’s informed consent.” (UNESCO 2005)

Is your school pressuring you to consent to vaccination of your child, despite the potential risk, and thus forcing you into an ongoing experiment? This is a clear violation of the principles of informed consent to medical experimentation.

According to official regulatory documents from Health Canada, the safety data is inadequate:

“The safety and efficacy of Pfizer-BioNTech COVID-19 Vaccine in pregnant women have not yet been established.” (Sect. 7.1, p. 12)

“It is unknown whether Pfizer-BioNTech COVID-19 Vaccine is excreted in human milk. A risk to the newborns/infants cannot be excluded.” (Sect. 7.1, p. 12)

Do you remember March 5, 2021? I do, because it was the day this article caught my attention: South Australian doctor receives first AstraZeneca vaccination shot in Australia – (ABC News). My eye was drawn to a particular statement made by the featured doctor, and also the fact that ABC decided to use this as the headline quote:

“I am immunocompromised myself … it's really important to have that health protection not only for myself, not only for my workers but also for the people who we serve, which is the public.”

One wonders, did the featured doctor actually read the Product Information from AstraZeneca prior to making this statement? Did the journalist examine the Product Information before deciding to highlight this statement? Either way, here's what both the doctor and the media outlet failed to mention:

“The immunogenicity, efficacy and safety of COVID-19 Vaccine AstraZeneca has not been assessed in immunocompromised individuals, including those receiving immunosuppressive therapy. The immunogenicity of vaccines may be lower in immunosuppressed patients.” (Sect. 4.4, p. 4)

Now, wouldn't you think it's a good idea – if you're being honest, responsible and indeed, professional – to inform immunocompromised people that the vaccine you are promoting to them has “not been assessed” for “efficacy and safety”? “Okay”, I know you're thinking, “I'll just take one of the other vaccines instead; surely they have been tested more thoroughly?” Let's find out.

What does Pfizer say?:

“The efficacy, safety and immunogenicity of COMIRNATY has not been assessed in immunocompromised individuals, including those receiving immunosuppressant therapy. The efficacy of COMIRNATY may be lower in immunosuppressed individuals.” (Sect. 4.4, p. 7)

No luck there. What about Janssen Biotech?:

“The efficacy, safety and immunogenicity of the vaccine have not been assessed in immunocompromised individuals, including those receiving immunosuppressant therapy. The efficacy of COVID-19 Vaccine Janssen may be lower in immunosuppressed individuals.” (Sect. 4.4, p. 3)

Lucky last. Moderna?

“The efficacy, safety and immunogenicity of the vaccine has not been assessed in immunocompromised individuals, including those receiving immunosuppressant therapy. The efficacy of SPIKEVAX may be lower in immunosuppressed individuals.” (Sect. 4.4, p. 6)

Well, there you have it. Not one Covid vaccine listed for use on the Australian population has any safety data assessment for immunocompromised individuals. If you're immunocompromised, don't expect the media and/or the medical profession to inform you of the lack of relevant safety data.

You will no doubt have heard, in the media, that the Covid AstraZeneca vaccine is recommended for older people. You could be forgiven, amongst all the media hype, for assuming the vaccine is perfectly safe for older people. But is this true?

Actually, upon closer inspection, we learn the safety data is lacking. According to AstraZeneca's official Product Information:

“There are currently limited data available for the efficacy and safety in individuals over 65 years of age. Further information will be collected from ongoing clinical studies and post-market monitoring. The decision to immunise an elderly patient should be decided on a case-by-case basis with consideration of age, co-morbidities, their environment, potential benefits and potential risks.” (Sect. 4.4., p. 5)

Keep in mind that “post-market monitoring” is a more sanitised way of telling you this is, in fact, an ongoing experiment.

If you're a younger bloke hoping to score some virtue signalling points on social media by 'rolling up your sleeve', you may want to first consider the following (as reported in Pfizer's official Product Information):

“Very rare cases of myocarditis and pericarditis have been observed following vaccination with COMIRNATY. These cases have primarily occurred within 14 days following vaccination, more often after the second vaccination, and more often in younger men... Vaccinees should be instructed to seek immediate medical attention if they develop symptoms indicative of myocarditis or pericarditis such as (acute and persisting) chest pain, shortness of breath, or palpitations following vaccination.” (Sect. 4.4, p. 6)

And keep in mind that your local GP may not be able help you. He or she will need to consult a specialist:

“Healthcare professionals should consult guidance and/or specialists to diagnose and treat this condition.” (Sect. 4.4, p. 6)